{
    "other_tests": [
        {
            "procedure_name": "Whole-exome sequencing",
            "date": "Not specified",
            "findings": "Identified novel heterozygous variants in ACAN, which encodes aggrecan, associated with short stature, advanced bone age, and premature growth cessation.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Bone age assessment",
            "date": "Not specified",
            "findings": "In Family 1, bone age was advanced at 9.0 years when chronologic age was 5 years 2 months. Remained advanced approximately 4 years above chronologic age.",
            "changes_over_time": "In Family 3, advanced bone age of 13 years at 11 years 7 months confirmed by repeat assessments."
        },
        {
            "procedure_name": "Skeletal survey",
            "date": "At 7 years and 5 months of age",
            "findings": "Normal with no signs of skeletal dysplasia.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Endocrine evaluation",
            "date": "Not specified",
            "findings": "Normal with no indications of GH deficiency, hypothyroidism, early puberty, or increased sex steroid production.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Bone mineral density assessment using Dual X-ray Absorptiometry",
            "date": "Not specified",
            "findings": "Bone mineral densities in the normal range.",
            "changes_over_time": "Not specified"
        }
    ]
}